The rising incidence of infectious diseases and shift in focus from centralized laboratories to decentralized (POC) point-of-care testing is driving the market demand.
Vancouver, BC -- (SBWIRE) -- 03/16/2021 -- The global Infectious Disease Rapid Diagnostic Testing Market is forecasted to be worth USD 3.56 Billion by 2027, according to a current analysis by Emergen Research. The rising cases of infectious disease all over the globe and the need for the immediate diagnosis will propel market growth. The evolving pathogens and rise in the occurrence of hospital-acquired infections (HAIs) are creating a need for a quick diagnosis of the diseases to stop the spread. Governments all over the world are investing in rapid diagnostic testing kits to increase their rate of testing and prevent any sort of epidemic.
Request for a sample report here@ https://www.emergenresearch.com/request-sample/269
It strives to offer accurate insights into the existing competitive landscape and the ever-growing competition in the industry. It also provides an idea about the strategic initiatives undertaken by the companies to fortify their footing in the market. The research report draws focus on the strengths and weaknesses of the key players of the market through a comprehensive SWOT analysis and Porter's Five Forces analysis to project the growth rate.
Key participants include Abbott Laboratories, Danaher Corporation, BGI Group, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Luminex Corporation, bioMérieux S.A., Hologic, Inc., Thermo Fisher Scientific Inc., and Becton, Dickinson, and Company, among others.
For the purpose of this report, Emergen Research has segmented into the global infectious disease rapid diagnostic testing market on the basis of product, technology, disease, end-user, and region:
Product Outlook (Revenue, USD Billion; 2017-2027)
Platforms
Assays
Technology Outlook (Revenue, USD Billion; 2017-2027)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Enzyme Immunoassay (EIA)
Real-Time PCR (q-PCR)
Lateral Flow Immunoassay (LFIA)
Others
Disease Outlook (Revenue, USD Billion; 2017-2027)
Bacterial Infection
CT/NG
HAIs
Tuberculosis
Others
Viral Infection
Hepatitis
Influenza Virus
HPV
HIV-AIDS
Others
Others Infections
End-User Outlook (Revenue, USD Billion; 2017-2027)
Clinics
Hospital
Diagnostic Center
Others
Regional Outlook (Revenue, USD Billion; 2017-2027)
North America
S.
Canada
Europe
Germany
UK
France
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
MEA
Saudi Arabia
UAE
Rest of MEA
Make an Inquiry of this report @ https://www.emergenresearch.com/purchase-enquiry/269
Objectives of the Global Infectious Disease Rapid Diagnostic Testing Market Study:
An in-depth study of the evolving market sectors and the growth & penetration status of the global Infectious Disease Rapid Diagnostic Testing market
COVID-19 Impact Analysis to highlight the major opportunities and challenges
Strategic recommendations to help readers formulate lucrative business strategies
Identification of the emerging players and their tactical approaches to expand market presence
An extensive study of the product portfolios of the major market players and their regional presence
A closer look at the strategic initiatives undertaken by the leading companies across this industry, including mergers & acquisitions, collaborations, partnerships, and joint ventures
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Infectious Disease Rapid Diagnostic Testing Market Segmentation & Impact Analysis
4.1. Infectious Disease Rapid Diagnostic Testing Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing prevalence of infectious diseases
4.2.2.2. Growth in funding for research on infectious disease diagnostics
4.2.3. Market restraints analysis
4.2.3.1. Inadequate reimbursements
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter's Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Infectious Disease Rapid Diagnostic Testing Market By Product Insights & Trends Revenue (USD Million)
5.1. Product Dynamics & Market Share, 2019 & 2027
5.1.1. Platforms
5.1.2. Assays
Chapter 6. Infectious Disease Rapid Diagnostic Testing Market By Technology Insights & Trends Revenue (USD Million)
6.1. Technology Dynamics & Market Share, 2019 & 2027
6.1.1. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.1.2. Enzyme Immunoassay (EIA)
6.1.3. Real-Time PCR (q-PCR)
6.1.4. Lateral Flow Immunoassay (LFIA)
6.1.5. Others
Chapter 7. Infectious Disease Rapid Diagnostic Testing Market By Diseases Insights & Trends Revenue (USD Million)
7.1. Diseases Dynamics & Market Share, 2019 & 2027
7.1.1. Bacterial Infection
7.1.1.1. CT/NG
7.1.1.2. HAIs
7.1.1.3. Tuberculosis
7.1.1.4. Others
7.1.2. Viral Infection
7.1.2.1. Hepatitis
7.1.2.2. Influenza Virus
7.1.2.3. HPV
7.1.2.4. HIV-AIDS
7.1.2.5. Others
7.1.3. Others Infections
CONTINUED..!!
Take a Look at our Related Reports:
Healthcare Business Intelligence Market Size
Ambulatory EHR Market Share
Healthcare CRM Market Growth
Fiber Cement Market Trends
Dairy Enzymes Market Demand
Cold Plasma Market Revenue
Industrial Lubricants Market Statistics
Cooling Fabrics Market Key Players Opportunities
Drug Screening Market Analysis
Mammography Workstations Market Development Strategy
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-infectious-disease-rapid-diagnostic-testing-market